Charles River Laboratories International, Inc.
(NYSE: CRL)
Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") on behalf of stockholders. A class action complaint has been filed against Charles River. The complaint alleges that defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, defendants failed to disclose to investors that: (i) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (ii) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (iii) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (iv) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.